Caxton Associates (New York)’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-36,100	Closed	-$2.75M	–	487
2023 Q4	$2.75M	Hold	36,100	–	–	0.14%	86
2023 Q3	$2.5M	Buy	36,100 +23,203	+180%	+$1.86M	0.35%	54
2023 Q2	$1.22M	Sell	12,897 -4,014	-24%	-$349K	0.18%	123
2023 Q1	$1.4M	Sell	16,911 -5,489	-25%	-$431K	0.22%	95
2022 Q4	$1.67M	Buy	22,400 +5,005	+29%	+$386K	0.12%	60
2022 Q3	$1.44M	Buy	+17,395	New	+$1.67M	0.25%	54
2021 Q4	–	Sell	-3,604	Closed	-$408K	–	594
2021 Q3	$408K	Sell	3,604 -614	-15%	-$70.1K	0.06%	245
2021 Q2	$437K	Buy	+4,218	New	+$398K	0.06%	207
2020 Q4	–	Sell	-4,664	Closed	-$372K	–	196
2020 Q3	$372K	Buy	+4,664	New	+$364K	0.04%	158
2020 Q2	–	Sell	-9,807	Closed	-$617K	–	511
2020 Q1	$617K	Buy	9,807 +2,799	+40%	+$202K	0.12%	119
2019 Q4	$545K	Buy	+7,008	New	+$547K	0.1%	161
2019 Q1	–	Sell	-5,145	Closed	-$263K	–	415
2018 Q4	$263K	Sell	5,145 -5,394	-51%	-$273K	0.06%	204
2018 Q3	$612K	Hold	10,539	–	–	0.07%	201
2018 Q2	$511K	Buy	10,539 +726	+7%	+$33.9K	0.06%	238
2018 Q1	$456K	Buy	+9,813	New	+$426K	0.05%	269